Search Results

A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors (KEYNOTE-158) Brief Summary: In this study, participants with multiple types of advanced (unresectable and/or metastatic) solid tumors who have progressed on standard of care therapy will be treated with pembrolizumab (MK-3475) Key Eligibility Criteria: Histologically or cytologically-documented, advanced solid tumor…

MammaPrint, BluePrint, and Full-genome Data Linked with Clinical Data to Evaluate New Gene Expression Profiles: An Adaptable Registry (FLEX Registry) Brief Summary:  The FLEX Registry will be implemented to operate as a large-scale, population based, prospective registry. All patients with stage I to III breast cancer who receive MammaPrint® and BluePrint testing on a primary…

Jaynah Mistry is a physician assistant with over 8 years of experience in inpatient hospital medicine. She graduated with her masters from Rochester Institute of Technology in 2016. She has been with MOH since January of 2022.

Ali Bukhari, MD, MS, is a medical oncologist and hematologist at Maryland Oncology Hematology. Dr. Bukhari earned a Bachelor of Science in molecular biology from University of Connecticut before receiving a Master of Medical Science from Drexel University and a Master of Science in clinical nutrition from Columbia University. He earned his Doctor of Medicine…